FDX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 7.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
9.915400E-01
Normal-vs-Stage2
7.828400E-01
Normal-vs-Stage3
3.185200E-01
Normal-vs-Stage4
7.752200E-01
Stage1-vs-Stage2
7.204800E-01
Stage1-vs-Stage3
3.047600E-01
Stage1-vs-Stage4
7.945200E-01
Stage2-vs-Stage3
1.805240E-01
Stage2-vs-Stage4
9.314000E-01
Stage3-vs-Stage4
2.367000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
7.015200E-01
Normal-vs-AfricanAmerican
6.688200E-01
Normal-vs-Asian
6.940800E-01
Caucasian-vs-AfricanAmerican
1.528200E-01
Caucasian-vs-Asian
8.799000E-01
AfricanAmerican-vs-Asian
2.433000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
7.456400E-01
Normal-vs-Female
7.433400E-01
Male-vs-Female
9.553000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
3.000800E-01
Normal-vs-Age(41-60Yrs)
9.373800E-01
Normal-vs-Age(61-80Yrs)
6.553600E-01
Normal-vs-Age(81-100Yrs)
4.769400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.616400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.157400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.635190E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.722200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.509240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
7.581600E-01
Normal-vs-Daily Drinker
7.920600E-01
Normal-vs-Weekly Drinker
6.293600E-01
Normal-vs-Occasional Drinker
8.992000E-01
Normal-vs-Social Drinker
2.182800E-01
Non Drinker-vs-Daily Drinker
9.718400E-01
Non Drinker-vs-Weekly Drinker
5.978400E-01
Non Drinker-vs-Occasional Drinker
3.707600E-01
Non Drinker-vs-Social Drinker
1.721640E-01
Daily Drinker-vs-Weekly Drinker
6.180200E-01
Daily Drinker-vs-Occasional Drinker
4.401200E-01
Daily Drinker-vs-Social Drinker
1.621980E-01
Weekly Drinker-vs-Occasional Drinker
2.557400E-01
Weekly Drinker-vs-Social Drinker
5.658400E-01
Occasional Drinker-vs-Social Drinker
3.764000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
7.564000E-02
Normal-vs-Grade 2
4.096000E-03
Normal-vs-Grade 3
2.776000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.800410E-01
Grade 1-vs-Grade 3
3.819200E-01
Grade 1-vs-Grade 4
7.564000E-02
Grade 2-vs-Grade 3
6.201400E-01
Grade 2-vs-Grade 4
4.096000E-03
Grade 3-vs-Grade 4
2.776000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
5.160400E-01
Normal-vs-NonDiabetic
7.497000E-01
Diabetic-vs-NonDiabetic
1.448230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
8.836600E-01
Normal-vs-NoPancreatitis
6.764800E-01
Pancreatitis-vs-NoPancreatitis
6.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
6.957000E-01
Normal-vs-N1
7.983200E-01
N0-vs-N1
7.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
9.615600E-01
Normal-vs-TP53-NonMutant
3.026000E-01
TP53-Mutant-vs-TP53-NonMutant
9.954500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap